103 related articles for article (PubMed ID: 3309131)
1. Effects of antihypertensive medications on vitality and well-being.
Levine S; Croog SH; Sudilovsky A; Testa MA
J Fam Pract; 1987 Oct; 25(4):357-63. PubMed ID: 3309131
[TBL] [Abstract][Full Text] [Related]
2. The effects of antihypertensive therapy on the quality of life.
Croog SH; Levine S; Testa MA; Brown B; Bulpitt CJ; Jenkins CD; Klerman GL; Williams GH
N Engl J Med; 1986 Jun; 314(26):1657-64. PubMed ID: 3520318
[TBL] [Abstract][Full Text] [Related]
3. Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications.
Croog SH; Levine S; Sudilovsky A; Baume RM; Clive J
Arch Intern Med; 1988 Apr; 148(4):788-94. PubMed ID: 3281619
[TBL] [Abstract][Full Text] [Related]
4. Work performance, absenteeism and antihypertensive medications.
Croog SH; Sudilovsky A; Levine S; Testa MA
J Hypertens Suppl; 1987 Feb; 5(1):S47-54. PubMed ID: 3553496
[TBL] [Abstract][Full Text] [Related]
5. Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide.
Williams GH; Croog SH; Levine S; Testa MA; Sudilovsky A
J Hypertens Suppl; 1987 Feb; 5(1):S29-35. PubMed ID: 3553493
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive therapy and quality of life.
Rakel RE
Am Fam Physician; 1987 Mar; 35(3):221-6. PubMed ID: 3548293
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
Yodfat Y; Bar-On D; Amir M; Cristal N
J Hum Hypertens; 1996 Feb; 10(2):117-22. PubMed ID: 8867566
[TBL] [Abstract][Full Text] [Related]
8. [The effect of long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents on the quality of life in patients with mild and moderate arterial hypertension. The Multicenter Captopril and the Quality of Life Study. The working group of the Multicenter Captopril and the Quality of Life Study].
Metelitsa VI; Duda SG; Ostrovskaia TP; Filatova NP; Mukhamedzhanova GF; Vygodin VA; Siegrist J; Broer M
Ter Arkh; 1995; 67(9):45-50. PubMed ID: 7495042
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of captopril and methyldopa monotherapy for hypertension: double-blind study in Indians.
Tahiliani R; Khokhani RC; Damle VB; Dadkar VN; Jaguste VS; Patel K; Raghu CN; Oke VG
Clin Ther; 1986; 8(5):482-9. PubMed ID: 3533264
[TBL] [Abstract][Full Text] [Related]
10. Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group.
Schoenberger JA; Croog SH; Sudilovsky A; Levine S; Baume RM
Am J Hypertens; 1990 Feb; 3(2):123-32. PubMed ID: 2407265
[TBL] [Abstract][Full Text] [Related]
11. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
Amir M; Cristal N; Bar-On D; Loidl A
Blood Press Suppl; 1994; 1():40-2. PubMed ID: 8205297
[TBL] [Abstract][Full Text] [Related]
12. Serum zinc is unaffected by effective captopril treatment of hypertension.
O'Connor DT; Strause L; Saltman P; Parmer RJ; Cervenka J
J Clin Hypertens; 1987 Dec; 3(4):405-8. PubMed ID: 3330985
[TBL] [Abstract][Full Text] [Related]
13. Captopril as a replacement for multiple therapy in hypertension: a controlled study.
Yodfat Y; Fidel J; Bloom DS
J Hypertens Suppl; 1985 Nov; 3(2):S155-8. PubMed ID: 3910775
[TBL] [Abstract][Full Text] [Related]
14. Beyond blood pressure control. Effect of antihypertensive therapy on quality of life.
Williams GH
Am J Hypertens; 1988 Oct; 1(4 Pt 2):363S-365S. PubMed ID: 3056445
[TBL] [Abstract][Full Text] [Related]
15. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
16. [The long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents of patients with mild and moderate arterial hypertension. The Multicenter Captopril and the Quality of Life Study. The working group of the Multicenter Captopril and the Quality of Life Study].
Metelitsa VI; Ostrovskaia TP; Duda SG; Filatova NP; Vygodin VA
Ter Arkh; 1995; 67(6):15-20. PubMed ID: 7667771
[TBL] [Abstract][Full Text] [Related]
17. Comparison of low-dose captopril and propranolol as second-line drugs in mild and moderate hypertension.
Traub YM; Rosenfeld JB
Isr J Med Sci; 1985 Sep; 21(9):737-41. PubMed ID: 3902720
[TBL] [Abstract][Full Text] [Related]
18. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibitors and quality of life: the European trial.
Hill JF; Bulpitt CJ; Fletcher AE
J Hypertens Suppl; 1985 Nov; 3(2):S91-4. PubMed ID: 3003305
[TBL] [Abstract][Full Text] [Related]
20. [The Multicenter Captopril and the Quality of Life Study: the effect of antihypertensive agents from the basic groups on the quality of life of patients in different populations. The working group of the Multicenter Captopril and the Quality of Life Study].
Metelitsa VI; Duda SG; Ostrovskaia TP; Filatova NP; Mukhamedzhanova GF; Vygodin VA; Broer M; Siegrist I
Ter Arkh; 1996; 68(4):29-36. PubMed ID: 9324785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
